Asad Haider Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Asad Haider

Stock Analyst at Goldman Sachs

(3.76)
# 2149
Out of 5,493 analysts
8
Total ratings
Success rate
Average return

8 Stocks

Name Action PT Current % Upside Ratings Updated
PCVX Vaxcyte
Initiates Coverage On: Neutral
38
33.98 11.83% 1 Sep 12, 2025
NAMS NewAmsterdam Pharma ...
Initiates Coverage On: Neutral
27
28.5 -5.26% 1 Jul 17, 2025
BNTX BioNTech
Initiates Coverage On: Neutral
110
98.08 12.15% 1 May 29, 2025
JNJ Johnson & Johnson
Upgrades: Buy
157 172
179.71 -4.29% 1 Apr 9, 2025
LLY Eli Lilly
Upgrades: Buy
892 888
724.6 22.55% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
194
220.68 -12.09% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 25
23.76 5.22% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
67 55
44.1 24.72% 1 Apr 8, 2025